Global Non-prescription Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-prescription Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Non-prescription Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Non-prescription Drugs by Country/Region, 2017, 2022 & 2028

2.2 Non-prescription Drugs Segment by Type

2.2.1 Brand Drugs

2.2.2 Generic Drug

2.3 Non-prescription Drugs Sales by Type

2.3.1 Global Non-prescription Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Non-prescription Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Non-prescription Drugs Sale Price by Type (2017-2022)

2.4 Non-prescription Drugs Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Other

2.5 Non-prescription Drugs Sales by Application

2.5.1 Global Non-prescription Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Non-prescription Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Non-prescription Drugs Sale Price by Application (2017-2022)

3 Global Non-prescription Drugs by Company

3.1 Global Non-prescription Drugs Breakdown Data by Company

3.1.1 Global Non-prescription Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Non-prescription Drugs Sales Market Share by Company (2020-2022)

3.2 Global Non-prescription Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Non-prescription Drugs Revenue by Company (2020-2022)

3.2.2 Global Non-prescription Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Non-prescription Drugs Sale Price by Company

3.4 Key Manufacturers Non-prescription Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-prescription Drugs Product Location Distribution

3.4.2 Players Non-prescription Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Non-prescription Drugs by Geographic Region

4.1 World Historic Non-prescription Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Non-prescription Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Non-prescription Drugs Annual Revenue by Geographic Region

4.2 World Historic Non-prescription Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Non-prescription Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Non-prescription Drugs Annual Revenue by Country/Region

4.3 Americas Non-prescription Drugs Sales Growth

4.4 APAC Non-prescription Drugs Sales Growth

4.5 Europe Non-prescription Drugs Sales Growth

4.6 Middle East & Africa Non-prescription Drugs Sales Growth

5 Americas

5.1 Americas Non-prescription Drugs Sales by Country

5.1.1 Americas Non-prescription Drugs Sales by Country (2017-2022)

5.1.2 Americas Non-prescription Drugs Revenue by Country (2017-2022)

5.2 Americas Non-prescription Drugs Sales by Type

5.3 Americas Non-prescription Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-prescription Drugs Sales by Region

6.1.1 APAC Non-prescription Drugs Sales by Region (2017-2022)

6.1.2 APAC Non-prescription Drugs Revenue by Region (2017-2022)

6.2 APAC Non-prescription Drugs Sales by Type

6.3 APAC Non-prescription Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Non-prescription Drugs by Country

7.1.1 Europe Non-prescription Drugs Sales by Country (2017-2022)

7.1.2 Europe Non-prescription Drugs Revenue by Country (2017-2022)

7.2 Europe Non-prescription Drugs Sales by Type

7.3 Europe Non-prescription Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-prescription Drugs by Country

8.1.1 Middle East & Africa Non-prescription Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Non-prescription Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Non-prescription Drugs Sales by Type

8.3 Middle East & Africa Non-prescription Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Non-prescription Drugs

10.3 Manufacturing Process Analysis of Non-prescription Drugs

10.4 Industry Chain Structure of Non-prescription Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Non-prescription Drugs Distributors

11.3 Non-prescription Drugs Customer

12 World Forecast Review for Non-prescription Drugs by Geographic Region

12.1 Global Non-prescription Drugs Market Size Forecast by Region

12.1.1 Global Non-prescription Drugs Forecast by Region (2023-2028)

12.1.2 Global Non-prescription Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Non-prescription Drugs Forecast by Type

12.7 Global Non-prescription Drugs Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Non-prescription Drugs Product Offered

13.1.3 Pfizer Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Non-prescription Drugs Product Offered

13.2.3 Roche Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Non-prescription Drugs Product Offered

13.3.3 Sanofi Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Non-prescription Drugs Product Offered

13.4.3 Johnson & Johnson Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Merck & Co. (MSD)

13.5.1 Merck & Co. (MSD) Company Information

13.5.2 Merck & Co. (MSD) Non-prescription Drugs Product Offered

13.5.3 Merck & Co. (MSD) Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck & Co. (MSD) Main Business Overview

13.5.5 Merck & Co. (MSD) Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Non-prescription Drugs Product Offered

13.6.3 Novartis Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 AbbVie

13.7.1 AbbVie Company Information

13.7.2 AbbVie Non-prescription Drugs Product Offered

13.7.3 AbbVie Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AbbVie Main Business Overview

13.7.5 AbbVie Latest Developments

13.8 Gilead Sciences

13.8.1 Gilead Sciences Company Information

13.8.2 Gilead Sciences Non-prescription Drugs Product Offered

13.8.3 Gilead Sciences Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Gilead Sciences Main Business Overview

13.8.5 Gilead Sciences Latest Developments

13.9 GlaxoSmithKline (GSK)

13.9.1 GlaxoSmithKline (GSK) Company Information

13.9.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Offered

13.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline (GSK) Main Business Overview

13.9.5 GlaxoSmithKline (GSK) Latest Developments

13.10 Amgen

13.10.1 Amgen Company Information

13.10.2 Amgen Non-prescription Drugs Product Offered

13.10.3 Amgen Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Amgen Main Business Overview

13.10.5 Amgen Latest Developments

13.11 AstraZeneca

13.11.1 AstraZeneca Company Information

13.11.2 AstraZeneca Non-prescription Drugs Product Offered

13.11.3 AstraZeneca Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AstraZeneca Main Business Overview

13.11.5 AstraZeneca Latest Developments

13.12 Bristol-Myers Squibb

13.12.1 Bristol-Myers Squibb Company Information

13.12.2 Bristol-Myers Squibb Non-prescription Drugs Product Offered

13.12.3 Bristol-Myers Squibb Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bristol-Myers Squibb Main Business Overview

13.12.5 Bristol-Myers Squibb Latest Developments

13.13 Eli Lilly

13.13.1 Eli Lilly Company Information

13.13.2 Eli Lilly Non-prescription Drugs Product Offered

13.13.3 Eli Lilly Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Eli Lilly Main Business Overview

13.13.5 Eli Lilly Latest Developments

13.14 Teva

13.14.1 Teva Company Information

13.14.2 Teva Non-prescription Drugs Product Offered

13.14.3 Teva Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Teva Main Business Overview

13.14.5 Teva Latest Developments

13.15 Bayer

13.15.1 Bayer Company Information

13.15.2 Bayer Non-prescription Drugs Product Offered

13.15.3 Bayer Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Bayer Main Business Overview

13.15.5 Bayer Latest Developments

13.16 Novo Nordisk

13.16.1 Novo Nordisk Company Information

13.16.2 Novo Nordisk Non-prescription Drugs Product Offered

13.16.3 Novo Nordisk Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novo Nordisk Main Business Overview

13.16.5 Novo Nordisk Latest Developments

13.17 Allergan

13.17.1 Allergan Company Information

13.17.2 Allergan Non-prescription Drugs Product Offered

13.17.3 Allergan Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Allergan Main Business Overview

13.17.5 Allergan Latest Developments

13.18 Takeda

13.18.1 Takeda Company Information

13.18.2 Takeda Non-prescription Drugs Product Offered

13.18.3 Takeda Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Takeda Main Business Overview

13.18.5 Takeda Latest Developments

13.19 Boehringer Ingelheim

13.19.1 Boehringer Ingelheim Company Information

13.19.2 Boehringer Ingelheim Non-prescription Drugs Product Offered

13.19.3 Boehringer Ingelheim Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Boehringer Ingelheim Main Business Overview

13.19.5 Boehringer Ingelheim Latest Developments

13.20 Takeda

13.20.1 Takeda Company Information

13.20.2 Takeda Non-prescription Drugs Product Offered

13.20.3 Takeda Non-prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Takeda Main Business Overview

13.20.5 Takeda Latest Developments

14 Research Findings and Conclusion

Table 1. Non-prescription Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Non-prescription Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Brand Drugs

Table 4. Major Players of Generic Drug

Table 5. Global Non-prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Non-prescription Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Non-prescription Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Non-prescription Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Non-prescription Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Non-prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Non-prescription Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Non-prescription Drugs Revenue by Application (2017-2022)

Table 13. Global Non-prescription Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Non-prescription Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Non-prescription Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Non-prescription Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Non-prescription Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Non-prescription Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Non-prescription Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Non-prescription Drugs Producing Area Distribution and Sales Area

Table 21. Players Non-prescription Drugs Products Offered

Table 22. Non-prescription Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Non-prescription Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Non-prescription Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Non-prescription Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Non-prescription Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Non-prescription Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Non-prescription Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Non-prescription Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Non-prescription Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Non-prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Non-prescription Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Non-prescription Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Non-prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Non-prescription Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Non-prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Non-prescription Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Non-prescription Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Non-prescription Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Non-prescription Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Non-prescription Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Non-prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Non-prescription Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Non-prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Non-prescription Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Non-prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Non-prescription Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Non-prescription Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Non-prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Non-prescription Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Non-prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Non-prescription Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Non-prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Non-prescription Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Non-prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Non-prescription Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Non-prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Non-prescription Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Non-prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Non-prescription Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Non-prescription Drugs

Table 66. Key Market Challenges & Risks of Non-prescription Drugs

Table 67. Key Industry Trends of Non-prescription Drugs

Table 68. Non-prescription Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Non-prescription Drugs Distributors List

Table 71. Non-prescription Drugs Customer List

Table 72. Global Non-prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Non-prescription Drugs Sales Market Forecast by Region

Table 74. Global Non-prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Non-prescription Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Non-prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Non-prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Non-prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Non-prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Non-prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Non-prescription Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Non-prescription Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Non-prescription Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Non-prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Non-prescription Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Non-prescription Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Non-prescription Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Non-prescription Drugs Product Offered

Table 94. Pfizer Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Roche Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Roche Non-prescription Drugs Product Offered

Table 99. Roche Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Roche Main Business

Table 101. Roche Latest Developments

Table 102. Sanofi Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Non-prescription Drugs Product Offered

Table 104. Sanofi Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Johnson & Johnson Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Johnson & Johnson Non-prescription Drugs Product Offered

Table 109. Johnson & Johnson Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Johnson & Johnson Main Business

Table 111. Johnson & Johnson Latest Developments

Table 112. Merck & Co. (MSD) Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Merck & Co. (MSD) Non-prescription Drugs Product Offered

Table 114. Merck & Co. (MSD) Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Merck & Co. (MSD) Main Business

Table 116. Merck & Co. (MSD) Latest Developments

Table 117. Novartis Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Non-prescription Drugs Product Offered

Table 119. Novartis Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. AbbVie Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. AbbVie Non-prescription Drugs Product Offered

Table 124. AbbVie Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. AbbVie Main Business

Table 126. AbbVie Latest Developments

Table 127. Gilead Sciences Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Gilead Sciences Non-prescription Drugs Product Offered

Table 129. Gilead Sciences Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Gilead Sciences Main Business

Table 131. Gilead Sciences Latest Developments

Table 132. GlaxoSmithKline (GSK) Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. GlaxoSmithKline (GSK) Non-prescription Drugs Product Offered

Table 134. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. GlaxoSmithKline (GSK) Main Business

Table 136. GlaxoSmithKline (GSK) Latest Developments

Table 137. Amgen Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Amgen Non-prescription Drugs Product Offered

Table 139. Amgen Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Amgen Main Business

Table 141. Amgen Latest Developments

Table 142. AstraZeneca Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. AstraZeneca Non-prescription Drugs Product Offered

Table 144. AstraZeneca Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. AstraZeneca Main Business

Table 146. AstraZeneca Latest Developments

Table 147. Bristol-Myers Squibb Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Bristol-Myers Squibb Non-prescription Drugs Product Offered

Table 149. Bristol-Myers Squibb Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Bristol-Myers Squibb Main Business

Table 151. Bristol-Myers Squibb Latest Developments

Table 152. Eli Lilly Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Eli Lilly Non-prescription Drugs Product Offered

Table 154. Eli Lilly Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Eli Lilly Main Business

Table 156. Eli Lilly Latest Developments

Table 157. Teva Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. Teva Non-prescription Drugs Product Offered

Table 159. Teva Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Teva Main Business

Table 161. Teva Latest Developments

Table 162. Bayer Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Bayer Non-prescription Drugs Product Offered

Table 164. Bayer Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Bayer Main Business

Table 166. Bayer Latest Developments

Table 167. Novo Nordisk Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Novo Nordisk Non-prescription Drugs Product Offered

Table 169. Novo Nordisk Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Novo Nordisk Main Business

Table 171. Novo Nordisk Latest Developments

Table 172. Allergan Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Allergan Non-prescription Drugs Product Offered

Table 174. Allergan Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Allergan Main Business

Table 176. Allergan Latest Developments

Table 177. Takeda Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. Takeda Non-prescription Drugs Product Offered

Table 179. Takeda Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 180. Takeda Main Business

Table 181. Takeda Latest Developments

Table 182. Boehringer Ingelheim Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. Boehringer Ingelheim Non-prescription Drugs Product Offered

Table 184. Boehringer Ingelheim Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 185. Boehringer Ingelheim Main Business

Table 186. Boehringer Ingelheim Latest Developments

Table 187. Takeda Basic Information, Non-prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Takeda Non-prescription Drugs Product Offered

Table 189. Takeda Non-prescription Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 190. Takeda Main Business

Table 191. Takeda Latest Developments

List of Figures

Figure 1. Picture of Non-prescription Drugs

Figure 2. Non-prescription Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-prescription Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Non-prescription Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Non-prescription Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Brand Drugs

Figure 10. Product Picture of Generic Drug

Figure 11. Global Non-prescription Drugs Sales Market Share by Type in 2021

Figure 12. Global Non-prescription Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Non-prescription Drugs Consumed in Hospital

Figure 14. Global Non-prescription Drugs Market: Hospital (2017-2022) & (K Units)

Figure 15. Non-prescription Drugs Consumed in Clinic

Figure 16. Global Non-prescription Drugs Market: Clinic (2017-2022) & (K Units)

Figure 17. Non-prescription Drugs Consumed in Other

Figure 18. Global Non-prescription Drugs Market: Other (2017-2022) & (K Units)

Figure 19. Global Non-prescription Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Non-prescription Drugs Revenue Market Share by Application in 2021

Figure 21. Non-prescription Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Non-prescription Drugs Revenue Market Share by Company in 2021

Figure 23. Global Non-prescription Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Non-prescription Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Non-prescription Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Non-prescription Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Non-prescription Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Non-prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Non-prescription Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Non-prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Non-prescription Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Non-prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Non-prescription Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Non-prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Non-prescription Drugs Sales Market Share by Country in 2021

Figure 36. Americas Non-prescription Drugs Revenue Market Share by Country in 2021

Figure 37. United States Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Non-prescription Drugs Sales Market Share by Region in 2021

Figure 42. APAC Non-prescription Drugs Revenue Market Share by Regions in 2021

Figure 43. China Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Non-prescription Drugs Sales Market Share by Country in 2021

Figure 50. Europe Non-prescription Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Non-prescription Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Non-prescription Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Non-prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Non-prescription Drugs in 2021

Figure 64. Manufacturing Process Analysis of Non-prescription Drugs

Figure 65. Industry Chain Structure of Non-prescription Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles